Core Viewpoint - Eastman Chemical reported a significant decline in earnings and sales for Q3 2025, reflecting ongoing challenges in demand and market conditions [2][3][9]. Financial Performance - Q3 2025 earnings were 40 cents per share, a 74% decrease from $1.53 in the same quarter last year [2]. - Adjusted earnings were $1.14 per share, down from $2.26 year-over-year, missing the Zacks Consensus Estimate of $1.18 [2]. - Revenues for the quarter were approximately $2.2 billion, a decline of 10.6% year-over-year, also missing the consensus estimate of $2.24 billion [3]. Segment Performance - **Advanced Materials**: Sales fell 7% year-over-year to $728 million, missing estimates due to weak demand in consumer discretionary markets [4]. - **Additives & Functional Products**: Sales were $716 million, down 4% from the previous year, affected by lower sales volume in construction and auto refinish markets [5]. - **Chemical Intermediaries**: Sales decreased 16% year-over-year to $499 million, driven by weak demand in the North American construction market [6]. - **Fibers**: Sales dropped 24% year-over-year to $254 million, primarily due to lower acetate tow volume [7]. Cash Flow and Debt - The company ended the quarter with cash and cash equivalents of $489 million and net debt of approximately $4.59 billion [8]. - Operating cash flow was $402 million, reflecting a 1.5% year-over-year increase [8]. - Eastman Chemical returned $146 million to shareholders through dividends and share repurchases during the quarter [8]. Guidance and Outlook - The company anticipates a challenging macroeconomic environment with cautious customer behavior due to tariff changes and soft demand [9]. - Eastman Chemical aims to cut over $75 million in costs this year and approximately $100 million in 2026, focusing on cost-reduction initiatives and improved plant efficiency [9]. - Full-year adjusted earnings are projected to be between $5.40 and $5.65 per share, with an expected operating cash flow of around $1 billion [10]. Market Sentiment - There has been a downward trend in estimates, with a consensus estimate shift of -24.73% [11]. - Eastman Chemical currently holds a Zacks Rank 4 (Sell), indicating expectations of below-average returns in the coming months [13]. - The stock has a poor Growth Score of F and a Momentum Score of F, but a strong Value Score of A [12].